GSK boss: Britain must reform drug pricing to become a life sciences superpower
The Guardian – World —
Shares jump on higher profits as Emma Walmsley is ‘hopeful’ standoff with NHS can be resolvedGSK’s outgoing chief executive, Emma Walmsley, has said Britain will struggle to be a “life sciences superpower” unless it overhauls drug pricing.As ministers draw up proposals to increase the amount the NHS spends on new medicines by up to 25%, Walmsley said she was “hopeful and ambitious” that the standoff with the pharma industry can be resolved. Continue reading...